NO20030483D0 - Assosiasjoner av dalfopristin/quinupristin med cefpirom - Google Patents

Assosiasjoner av dalfopristin/quinupristin med cefpirom

Info

Publication number: NO20030483D0
Authority: NO; Norway
Prior art keywords: dalfopristine; quinupristine; cefpiroma; associations; cefpirome
Prior art date: 2000-08-03

Application number

NO20030483A

Other languages

English (en)

Norwegian (no)

Other versions

NO20030483L (no

Inventor

Celine Feger

Philippe Moreillon

Jacques Vouillamoz

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-03

Filing date

2003-01-30

Publication date

2003-01-30

2003-01-30 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2003-01-30 Publication of NO20030483D0 publication Critical patent/NO20030483D0/no

2003-01-30 Publication of NO20030483L publication Critical patent/NO20030483L/no

Links

DKOQGJHPHLTOJR-WHRDSVKCSA-N cefpirome Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 DKOQGJHPHLTOJR-WHRDSVKCSA-N 0.000 title abstract 4
SUYRLXYYZQTJHF-VMBLUXKRSA-N dalfopristin Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1 SUYRLXYYZQTJHF-VMBLUXKRSA-N 0.000 title abstract 4
WTHRRGMBUAHGNI-LCYNINFDSA-N quinupristin Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2C[C@@H](CS[C@H]3C4CCN(CC4)C3)C(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O WTHRRGMBUAHGNI-LCYNINFDSA-N 0.000 title abstract 4
229960000466 cefpirome Drugs 0.000 abstract 3
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Thyristors (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

NO20030483A 2000-08-03 2003-01-30 Assosiasjoner av dalfopristin/quinupristin med cefpirom NO20030483L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0010245A FR2812549B1 (fr)	2000-08-03	2000-08-03	Associations dalfopristine/quinupristine avec le cefpirome
PCT/FR2001/002520 WO2002011751A2 (fr)	2000-08-03	2001-08-02	Associations dalfopristine/quinupristine avec le cefpirome

Publications (2)

Publication Number	Publication Date
NO20030483D0 true NO20030483D0 (no)	2003-01-30
NO20030483L NO20030483L (no)	2003-01-30

Family

ID=8853264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030483A NO20030483L (no)	2000-08-03	2003-01-30	Assosiasjoner av dalfopristin/quinupristin med cefpirom

Country Status (28)

Country	Link
US (2)	US7005416B2 (cs)
EP (1)	EP1313500B1 (cs)
JP (1)	JP2004505926A (cs)
KR (1)	KR100808715B1 (cs)
CN (1)	CN1256982C (cs)
AR (1)	AR033992A1 (cs)
AT (1)	ATE279204T1 (cs)
AU (2)	AU8409501A (cs)
BR (1)	BR0112897A (cs)
CA (1)	CA2418023A1 (cs)
CZ (1)	CZ2003290A3 (cs)
DE (1)	DE60106463T2 (cs)
DK (1)	DK1313500T3 (cs)
EA (1)	EA007713B1 (cs)
ES (1)	ES2230358T3 (cs)
FR (1)	FR2812549B1 (cs)
HU (1)	HU227455B1 (cs)
IL (1)	IL154237A0 (cs)
MX (1)	MXPA03000959A (cs)
NO (1)	NO20030483L (cs)
NZ (1)	NZ523982A (cs)
PE (1)	PE20020264A1 (cs)
PL (1)	PL204278B1 (cs)
PT (1)	PT1313500E (cs)
SK (1)	SK1202003A3 (cs)
TN (1)	TNSN01116A1 (cs)
WO (1)	WO2002011751A2 (cs)
ZA (1)	ZA200300903B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN107420042B (zh) *	2017-09-25	2023-03-31	中国地质大学（武汉）	一种基于六自由度并联机构的海底钻机自动调平系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0867676A (ja) *	1994-03-30	1996-03-12	Eisai Kagaku Kk	保護アミノチアゾリル酢酸誘導体
US5464616A (en) *	1994-08-04	1995-11-07	Synphar Laboratories, Ind.	6β-substituted penicillanic acids as beta-lactamase inhibitors
US5686441A (en) *	1995-08-04	1997-11-11	Syphar Laboratories, Inc.	Penam sulfones as β-lactamase inhibitors
FR2755857B1 (fr) *	1996-11-19	1998-12-24	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
US6187746B1 (en) *	1997-12-16	2001-02-13	Rhone-Poulenc Rorer S.A.	Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
US6465428B1 (en) *	1999-08-27	2002-10-15	Aventis Pharma S.A.	Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime

2000
- 2000-08-03 FR FR0010245A patent/FR2812549B1/fr not_active Expired - Fee Related
2001
- 2001-07-26 PE PE2001000759A patent/PE20020264A1/es not_active Application Discontinuation
- 2001-08-01 AR ARP010103684A patent/AR033992A1/es unknown
- 2001-08-01 TN TNTNSN01116A patent/TNSN01116A1/fr unknown
- 2001-08-02 MX MXPA03000959A patent/MXPA03000959A/es unknown
- 2001-08-02 NZ NZ523982A patent/NZ523982A/en not_active IP Right Cessation
- 2001-08-02 SK SK120-2003A patent/SK1202003A3/sk unknown
- 2001-08-02 PL PL365075A patent/PL204278B1/pl not_active IP Right Cessation
- 2001-08-02 DK DK01963045T patent/DK1313500T3/da active
- 2001-08-02 CA CA002418023A patent/CA2418023A1/fr not_active Abandoned
- 2001-08-02 CN CNB018148573A patent/CN1256982C/zh not_active Expired - Fee Related
- 2001-08-02 EP EP01963045A patent/EP1313500B1/fr not_active Expired - Lifetime
- 2001-08-02 DE DE60106463T patent/DE60106463T2/de not_active Expired - Lifetime
- 2001-08-02 IL IL15423701A patent/IL154237A0/xx unknown
- 2001-08-02 EA EA200300214A patent/EA007713B1/ru unknown
- 2001-08-02 KR KR1020037001575A patent/KR100808715B1/ko not_active Expired - Lifetime
- 2001-08-02 AT AT01963045T patent/ATE279204T1/de not_active IP Right Cessation
- 2001-08-02 AU AU8409501A patent/AU8409501A/xx active Pending
- 2001-08-02 JP JP2002517086A patent/JP2004505926A/ja active Pending
- 2001-08-02 PT PT01963045T patent/PT1313500E/pt unknown
- 2001-08-02 WO PCT/FR2001/002520 patent/WO2002011751A2/fr not_active Ceased
- 2001-08-02 AU AU2001284095A patent/AU2001284095B2/en not_active Ceased
- 2001-08-02 HU HU0300682A patent/HU227455B1/hu not_active IP Right Cessation
- 2001-08-02 BR BR0112897-3A patent/BR0112897A/pt not_active IP Right Cessation
- 2001-08-02 ES ES01963045T patent/ES2230358T3/es not_active Expired - Lifetime
- 2001-08-02 CZ CZ2003290A patent/CZ2003290A3/cs unknown
- 2001-08-03 US US09/920,810 patent/US7005416B2/en not_active Expired - Lifetime
2003
- 2003-01-30 NO NO20030483A patent/NO20030483L/no not_active Application Discontinuation
- 2003-01-31 ZA ZA200300903A patent/ZA200300903B/en unknown
2006
- 2006-01-04 US US11/325,919 patent/US20060122103A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60106463D1 (de)	2004-11-18
SK1202003A3 (en)	2003-07-01
CA2418023A1 (fr)	2002-02-14
HUP0300682A3 (en)	2004-09-28
JP2004505926A (ja)	2004-02-26
ATE279204T1 (de)	2004-10-15
FR2812549B1 (fr)	2003-03-21
BR0112897A (pt)	2003-06-10
ES2230358T3 (es)	2005-05-01
AU8409501A (en)	2002-02-18
WO2002011751A3 (fr)	2002-06-13
US7005416B2 (en)	2006-02-28
NO20030483L (no)	2003-01-30
IL154237A0 (en)	2003-07-31
EP1313500B1 (fr)	2004-10-13
AR033992A1 (es)	2004-01-21
KR100808715B1 (ko)	2008-02-29
TNSN01116A1 (fr)	2005-11-10
PL365075A1 (en)	2004-12-27
FR2812549A1 (fr)	2002-02-08
HU227455B1 (en)	2011-06-28
EA200300214A1 (ru)	2003-06-26
KR20030022351A (ko)	2003-03-15
PL204278B1 (pl)	2009-12-31
US20020037890A1 (en)	2002-03-28
DE60106463T2 (de)	2005-10-13
WO2002011751A2 (fr)	2002-02-14
AU2001284095B2 (en)	2007-04-05
ZA200300903B (en)	2003-11-10
EP1313500A2 (fr)	2003-05-28
PE20020264A1 (es)	2002-05-20
EA007713B1 (ru)	2006-12-29
HK1058305A1 (en)	2004-05-14
NZ523982A (en)	2004-10-29
CN1256982C (zh)	2006-05-24
MXPA03000959A (es)	2003-06-09
CZ2003290A3 (cs)	2003-05-14
US20060122103A1 (en)	2006-06-08
PT1313500E (pt)	2005-02-28
CN1449290A (zh)	2003-10-15
HUP0300682A2 (hu)	2003-08-28
DK1313500T3 (da)	2005-02-14

Similar Documents

Publication	Publication Date	Title
NO20050807L (no)	2005-02-15	Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
IL195723A (en)	2010-12-30	Use of p53 inhibitors for the preparation of medicament
DE69826644D1 (de)	2004-11-04	Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
ATE265857T1 (de)	2004-05-15	Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
DE60023476D1 (de)	2005-12-01	Kombination von doctaxel und rhumab her2 zür krebsbehandlung
ATE512163T1 (de)	2011-06-15	Verabreichung von mitteln zur behandlung von entzündungen
DK1346041T3 (da)	2007-07-02	Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
UA26213C2 (uk)	1999-07-19	Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
SE9900961D0 (sv)	1999-03-16	Novel compounds
SE9802208D0 (sv)	1998-06-22	Novel compounds
DE60124387D1 (de)	2006-12-21	Synergistische kombination zur behandlung von kolorektalkarzinom
DE60026491D1 (de)	2006-05-04	Melagatran zur behandlung von entzündungen
ATE395061T1 (de)	2008-05-15	Topische zusammensetzungen zur transdermalen gabe von niacin prodrugs sowie verfahren zur behandlung von hyperlipidämie
UA42719C2 (uk)	2001-11-15	Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
TR200102512T2 (tr)	2002-04-22	Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
NO20042758L (no)	2004-09-22	Fremgangsmate for behandling av en pasient som krever analgesi.
SE9902597D0 (sv)	1999-07-06	New use
SE9802209D0 (sv)	1998-06-22	Novel compounds
ATE359808T1 (de)	2007-05-15	Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DK1244438T3 (da)	2004-02-23	Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
NO20030483D0 (no)	2003-01-30	Assosiasjoner av dalfopristin/quinupristin med cefpirom
DE60236927D1 (de)	2010-08-19	Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
SE0004827D0 (sv)	2000-12-22	Therapeutic compounds
BG105984A (bg)	2002-04-30	Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
ATE371446T1 (de)	2007-09-15	Zusammensetzungen zur verhinderung der adhäsion

Legal Events

Date	Code	Title	Description
2008-03-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application